What is TREAT-NMD?

The TREAT-NMD Neuromuscular Network is a unique infrastructure focused on accelerating preclinical and clinical development across the neuromuscular field to improve patient treatment and care on an international scale. The network has 22 core "partners" (universities, patient organisations and pharmaceutical companies) in Europe and strategic partnerships with many more across the world. We offer our infrastructure and expertise to the pharmaceutical and biotech industry to bring promising new therapies into clinical trials.

All neuromuscular disorders are comparatively rare, and this creates a specific set of barriers to moving into a clinical trial. To ensure patient recruitment criteria are met, trials often have to be multinational, multicentre studies. The time taken to locate both the patient population and the specialist clinical centres with the expertise to run a trial can increase the costs of clinical studies significantly. 

Through the TREAT-NMD infrastructure we can provide you with the centres to conduct the trials and identify the patients to recruit into them, in accordance with your study inclusion criteria.